MENU
+Compare
ARSUF
Stock ticker: OTC
AS OF
Sep 26 closing price
Price
$23.50
Change
-$0.16 (-0.68%)
Capitalization
1.91B

ARSUF Fagron SA Forecast, Technical & Fundamental Analysis

Fagron SA is a pharmaceutical compounding company operating in Belgium... Show more

ARSUF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ARSUF with price predictions
Feb 03, 2026

ARSUF's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ARSUF turned positive on January 16, 2026. Looking at past instances where ARSUF's MACD turned positive, the stock continued to rise in of 14 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.321) is normal, around the industry mean (29.792). P/E Ratio (19.420) is within average values for comparable stocks, (74.095). ARSUF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.035). Dividend Yield (0.015) settles around the average of (0.029) among similar stocks. P/S Ratio (1.804) is also within normal values, averaging (116.680).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARSUF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARSUF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

View a ticker or compare two or three
ARSUF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

ARSUF paid dividends on May 19, 2021

Fagron SA ARSUF Stock Dividends
А dividend of $0.18 per share was paid with a record date of May 19, 2021, and an ex-dividend date of May 17, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Fascinatio Boulevard 350
Phone
+31 883311288
Employees
3567
Web
https://www.fagron.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWXPX11.060.02
+0.18%
Nationwide International Index Instl Svc
ACESX11.430.01
+0.09%
Invesco Equity and Income R
HSLSX43.76-0.08
-0.18%
Hartford Small Cap Growth R4
NGUAX28.98-0.52
-1.76%
Neuberger Large Cap Growth Inv
MGZZX17.95-0.54
-2.92%
Morgan Stanley Inst Global Insgt R6

ARSUF and Stocks

Correlation & Price change

A.I.dvisor tells us that ARSUF and CRDL have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARSUF and CRDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARSUF
1D Price
Change %
ARSUF100%
N/A
CRDL - ARSUF
22%
Poorly correlated
+6.17%
AVCNF - ARSUF
12%
Poorly correlated
-7.64%
BSPK - ARSUF
2%
Poorly correlated
N/A
BIOGY - ARSUF
2%
Poorly correlated
N/A
PRFX - ARSUF
2%
Poorly correlated
+1.01%
More

Groups containing ARSUF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARSUF
1D Price
Change %
ARSUF100%
N/A
Pharmaceuticals: Generic
industry (214 stocks)
-0%
Poorly correlated
-0.59%